Vue.component('cmr-overview', {
	template: 
		'<div>' +
			'<el-row id="cmr-title">' +
				'<h1 style="text-align: center">Completion Rate for Comprehensive Medication Review (CMR)</h1>' +
			'</el-row>' +
			'<el-row id="cmr-description" class="scrollspy">' +
				'<h2>Description</h2>' +
			'</el-row>' +
			'<el-row>' +
				'<p>The percentage of prescription drug plan members who met eligibility criteria for medication therapy management (MTM) services and who received a comprehensive medication review (CMR) during the eligibility period.</p>' +
				'<p>A higher rate indicates better performance.</p>' +
			'</el-row>' +
			'<el-row id="cmr-add-info" class="scrollspy">' +
				'<h2>Additional Information</h2>' +
			'</el-row>' +
			'<el-row>' +
				'<el-col :span="6">' +
					'<p><b>Intended Use</b></p>' +
				'</el-col>' +
				'<el-col :span="18">' +
					'<p>Performance measurement for prescription drug plan MTM programs; and MTM programs not related to a prescription drug plan.</p>' +
				'</el-col>' +
			'</el-row>' +
			'<el-row>' +
				'<el-col :span="6">' +
					'<p><b>Data Sources</b></p>' +
				'</el-col>' +
				'<el-col :span="18">' +
					'<p>MTM program data.</p>' +
				'</el-col>' +
			'</el-row>' +
			'<el-row>' +
				'<el-col :span="6">' +
					'<p><b>Denominator</b></p>' +
				'</el-col>' +
				'<el-col :span="18">' +
					'<p>Individuals 18 years of age or older enrolled in the MTM program and identified as eligible for CMR during the measurement year.</p>' +
				'</el-col>' +
			'</el-row>' +
			'<el-row>' +
				'<el-col :span="6">' +
					'<p><b>Exclusions</b></p>' +
				'</el-col>' +
				'<el-col :span="18">' +
					'<p>Hospice</p>' +
				'</el-col>' +
			'</el-row>' +
			'<el-row>' +
				'<el-col :span="6">' +
					'<p><b>Numerator</b></p>' +
				'</el-col>' +
				'<el-col :span="18">' +
					'<p>Individuals from the denominator that have received one or more CMRs during the measurement year.</p>' +
				'</el-col>' +
			'</el-row>' +
		'</div>'
});

Vue.component('cmr-ref-1', {
	template: '<el-popover placement="top-start" width="400" trigger="hover">' +
		'<span>Joint Commission of Pharmacy Practitioners. Medication Management Services (MMS) Definition and Key Points [Internet]. 2018 [cited 2018 Dec 3]. Available from: <a href="https://jcpp.net/wp-content/uploads/2018/05/Medication-Management-Services-Definition-and-Key-Points-Version-1.pdf" target="_blank">https://jcpp.net/wp-content/uploads/2018/05/Medication-Management-Services-Definition-and-Key-Points-Version-1.pdf</a>.</span>' +
		'<sup slot="reference">1</sup>' +
		'</el-popover>'
});

Vue.component('cmr-ref-2', {
	template: '<el-popover placement="top-start" width="400" trigger="hover">' +
		'<span>Centers for Medicare and Medicaid Services (CMS), HHS. Medicare Program; Medicare Prescription Drug Benefit, Final Rule. Federal Register [Internet]. 2005 [cited 2018 Dec 3]; 70:4193-4585. Available from: <a href="https://www.govinfo.gov/content/pkg/FR-2005-01-28/pdf/05-1321.pdf" target="_blank">https://www.govinfo.gov/content/pkg/FR-2005-01-28/pdf/05-1321.pdf</a>.</span>' +
		'<sup slot="reference">2</sup>' +
		'</el-popover>'
});

Vue.component('cmr-ref-3', {
	template: '<el-popover placement="top-start" width="400" trigger="hover">' +
		'<span>Larrick Chavez-Valdez A. CY 2019 Medication Therapy Management Program Guidance and Submission Instructions [Internet]. 2018 [cited 2018 Dec 3]. Available from: <a href="https://www.cms.gov/Medicare/Prescription-Drug-Coverage/PrescriptionDrugCovContra/Downloads/Memo-Contract-Year-2019-Medication-Therapy-Management-MTM-Program-Submission-v-040618.pdf" target="_blank">https://www.cms.gov/Medicare/Prescription-Drug-Coverage/PrescriptionDrugCovContra/Downloads/Memo-Contract-Year-2019-Medication-Therapy-Management-MTM-Program-Submission-v-040618.pdf</a>.</span>' +
		'<sup slot="reference">3</sup>' +
		'</el-popover>'
});

Vue.component('cmr-ref-4', {
	template: '<el-popover placement="top-start" width="400" trigger="hover">' +
		'<span>Agency for Healthcare Research and Quality. Effective Health Care Program Medication Therapy Management Interventions in Outpatient Settings Executive Summary [Internet]. 2014 [cited 2018 Dec 3]. Available from: <a href="https://effectivehealthcare.ahrq.gov/sites/default/files/related_files/medication-therapy-management_executive.pdf" target="_blank">https://effectivehealthcare.ahrq.gov/sites/default/files/related_files/medication-therapy-management_executive.pdf</a>.</span>' +
		'<sup slot="reference">4</sup>' +
		'</el-popover>'
});

Vue.component('cmr-ref-5', {
	template: '<el-popover placement="top-start" width="400" trigger="hover">' +
		'<span>Viswanathan M, Kahwati LC, Golin CE, et al. Medication therapy management interventions in outpatient settings: a systematic review and meta-analysis. JAMA Intern Med. 2015; 175(1):76-87. PMID: <a href="https://www.ncbi.nlm.nih.gov/pubmed/25401788" target="_blank">25401788</a>.</span>' +
		'<sup slot="reference">5</sup>' +
		'</el-popover>'
});

Vue.component('cmr-ref-6', {
	template: '<el-popover placement="top-start" width="400" trigger="hover">' +
		'<span>Perlroth D, Marrufo G, Montesinos A, et al. Medication Therapy Management in Chronically Ill Populations: Final Report. Executive Summary. August 2013. Available at: <a href="https://innovation.cms.gov/Files/reports/MTM_Final_Report.pdf" target="_blank">https://innovation.cms.gov/Files/reports/MTM_Final_Report.pdf</a>. Accessed 12/3/18.</span>' +
		'<sup slot="reference">6</sup>' +
		'</el-popover>'
});

Vue.component('cmr-ref-7', {
	template: '<el-popover placement="top-start" width="400" trigger="hover">' +
		'<span>Almodovar AS, Axon DR, Coleman AM, et al. The Effect of Plan Type and Comprehensive Medication Reviews on High-Risk Medication Use. J Manag Care Spec Pharm. 2018; 24(5):416-422. PMID: <a href="https://www.ncbi.nlm.nih.gov/pubmed/29694292" target="_blank">29694292</a>.</span>' +
		'<sup slot="reference">7</sup>' +
		'</el-popover>'
});

Vue.component('cmr-ref-8', {
	template: '<el-popover placement="top-start" width="400" trigger="hover">' +
		'<span>Wang Y, Farley JF, Ferreri SP, et al. Do comprehensive medication review completion rates predict medication use and management quality? [Internet]. Res Soc Adm Pharm. 2018 [cited 2018 Dec 3]. Available from: <a href="https://doi.org/10.1016/j.sapharm.2018.06.010" target="_blank">https://doi.org/10.1016/j.sapharm.2018.06.010</a>.</span>' +
		'<sup slot="reference">8</sup>' +
		'</el-popover>'
});

Vue.component('cmr-rationale', {
	template: 
		'<div>' +
			'<el-row id="cmr-rationale" class="scrollspy">' +
				'<h2>Rationale</h2>' +
			'</el-row>' +
			'<el-row>' +
				'<p>Medication management services are "a spectrum of patient-centered, pharmacist-provided, collaborative services that focus on medication appropriateness, effectiveness, safety, and adherence with the goal of improving health outcomes."' +
				'<cmr-ref-1></cmr-ref-1>' +
				' Medication therapy management (MTM) services represent one type of service under this broader umbrella. Since Medicare Part D inception, all Part D program sponsors (prescription drug plans and Medicare Advantage plans) are required to offer MTM services to beneficiaries meeting specific criteria.' +
				'<cmr-ref-2></cmr-ref-2>' +
				' Specifically, these services must include an annual comprehensive medication review (CMR) which is defined as "an interactive, person-to-person, or telehealth consultation performed by a pharmacist or other qualified provider."' +
				'<cmr-ref-3></cmr-ref-3>' +
				" CMRs enable the provider to perform a comprehensive assessment of a beneficiary's medications to identify and intervene on medication therapy problems and must be documented using a standardized format." +
				'<cmr-ref-3></cmr-ref-3>' +
				'</p>' +
				'<p>Recent national reports provide evidence regarding the effectiveness of MTM.' +
				'<cmr-ref-4></cmr-ref-4><sup>,</sup><cmr-ref-5></cmr-ref-5><sup>,</sup><cmr-ref-6></cmr-ref-6>' +
				" Viswanathan et al. reviewed 44 studies to assess the effect of MTM interventions. While insufficient data for some outcomes as well as inconsistent effects were noted as challenges, the review found that MTM was associated with improvements in medication appropriateness, adherence, dosing, and health plans' medication costs. In addition, MTM was associated with reduced odds of hospitalization and hospitalization costs for patients with diabetes or heart failure." +
				'<cmr-ref-4></cmr-ref-4><sup>,</sup><cmr-ref-5></cmr-ref-5>' +
				' Similarly, Perloth et al. conducted a mixed-methods evaluation of the effect of MTM on Medicare beneficiaries in 2010 and found that MTM was associated with improved medication adherence. Positive effects on adherence were greater for beneficiaries who received a CMR. In addition, MTM was associated with a reduced risk of hospitalization, emergency room visits, and hospitalization costs for patients with heart failure and diabetes, particularly for those who received CMRs.' +
				'<cmr-ref-6></cmr-ref-6>' +
				' More recently, researchers have examined whether CMR completion rates are associated with Plan performance on other medication-related quality measures.' +
				'<cmr-ref-7></cmr-ref-7><sup>,</sup><cmr-ref-8></cmr-ref-8>' +
				' Only modest associations were observed;' +
				'<cmr-ref-7></cmr-ref-7><sup>,</sup><cmr-ref-8></cmr-ref-8>' +
				' therefore, additional research exploring these associations is warranted.' +
				'</p>' +
			'</el-row>' +
			'<el-row>' +
			  '<p>Last Update: 12 Dec 2018</p>' +
			'</el-row>' +
		'</div>'
});

Vue.component('cmr', {
	template:
		'<div id="cmr" class="search-filter inview">' +
			'<cmr-overview></cmr-overview>' +
            '<cmr-rationale v-if="rationale"></cmr-rationale>' +
			'<br><br><br><br>' +
		'</div>',
	props: {
		rationale: {
			default: false
		},
		faqs: {
			default: false
		}
	}
});